Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Emerson Introduces Gas Chromatograph for Natural Gas, Biogas, Renewable Gas Measurement and...
Rosemount 470XA provides a compact and cost-effective solution for custody transfer, carbon capture and other applications of traditional and...
Emerson Ventures Invests in EECOMOBILITY
Strategic investment supports advanced AI software for rapid production testing of batteries
100+ St. Louis Area Educators Recognized by Emerson with Excellence in Teaching Awards
Local educators recognized for their dedication to students
